Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
01 1Biophore India Pharmaceuticals Pvt Ltd
02 1LGM Pharma
03 1Gonane Pharma
04 1Zhejiang Hengkang Pharmaceutical
05 1HRV Global Life Sciences
06 1Tagoor Laboratories
07 1Tofigh Daru
08 1Chunghwa Chemical Synthesis & Biotech
09 1Arene Lifesciences
10 2Aurore Life Sciences
11 1Bajaj Healthcare
12 1Beijing Mesochem Technology
13 1Cipla
14 1Curequest Lifescience
15 1Dalian Richon Chem
16 1Glenmark Pharmaceuticals
17 1Guangzhou Tosun Pharmaceutical
18 1Hetero Drugs
19 1Hikal
20 1Hunan Huateng Pharmaceutical Co ltd
21 1Lasa Supergenerics
22 1MSN Laboratories
23 1Mangalam Drugs & Organics Ltd
24 1Optimus Pharma
25 1PI Industries
26 1Shouyuan Chemical
27 1Solara Active Pharma Sciences
28 1Viruj Pharmaceuticals Pvt Ltd
29 1Zhejiang Hisun Pharmaceutical
01 7China
02 20India
03 1Iran
04 1Taiwan
05 1U.S.A
01 7Active
02 1Inactive
03 22Blank
01 30Blank
01 30Blank
01 1WC-0119A10
02 1ZJ210055
03 28Blank
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35048
Submission : 2020-08-31
Status : Active
Type : II
NDC Package Code : 73435-010
Start Marketing Date : 2020-12-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
Date of Issue : 2021-01-28
Valid Till : 2024-08-17
Written Confirmation Number : ZJ210055
Address of the Firm :
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
Tofigh Daru develops & synthesizes a diverse range of APIs in Anticancer, Narcotics, Cardiovascular to Immunomodulatory Segments.
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35849
Submission : 2021-06-17
Status : Active
Type : II
NDC Package Code : 52076-6265
Start Marketing Date : 2020-09-03
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35680
Submission : 2021-03-22
Status : Active
Type : II
Date of Issue : 2021-10-13
Valid Till : 2022-07-02
Written Confirmation Number : WC-0119A10
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35933
Submission : 2021-05-22
Status : Active
Type : II
We have 29 companies offering Favipiravir
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?